At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
DNA Ginkgo Bioworks Holdings Inc.
Closed Good Friday 04-02 16:00:00 EDT
6.90
+0.11
+1.62%
盘后6.99
+0.09+1.24%
19:56 EDT
High7.11Low6.40Vol1.44M
Open6.45D1 Closing6.79Amplitude10.46%
Mkt Cap427.28MTradable Cap286.60MTotal Shares61.92M
T/O9.89MT/O Rate3.46%Tradable Shares41.54M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Nyse Order Imbalance 221121.0 Shares on Buy Side
THOMSON REUTERS  ·  04-03 03:50
Nyse Order Imbalance 221121.0 Shares on Buy Side
New DNA Testing Links Ted Bundy to 1974 Murder of Utah Teen -- WSJ
Dow Jones  ·  04-02 06:02
New DNA Testing Links Ted Bundy to 1974 Murder of Utah Teen -- WSJ
DNA X, Inc. delays 2025 annual filing
TIPRANKS  ·  04-02 02:25
DNA X, Inc. delays 2025 annual filing
Six-Day Holiday Ignites Travel Enthusiasm: Spring Break Meets Qingming Festival
Deep News  ·  04-01 12:41
Six-Day Holiday Ignites Travel Enthusiasm: Spring Break Meets Qingming Festival
4basebio announces major expansion to support the growing demand of RUO and HQ synthetic DNA with lease of an innovation hub and manufacturing facility in Cambridge, UK
GlobeNewswire  ·  03-31
4basebio announces major expansion to support the growing demand of RUO and HQ synthetic DNA with lease of an innovation hub and manufacturing facility in Cambridge, UK
4basebio Leases New Cambridge Facility to Scale Synthetic DNA Manufacturing
TIPRANKS  ·  03-31
4basebio Leases New Cambridge Facility to Scale Synthetic DNA Manufacturing
AstraZeneca Expands DNA-Repair Oncology Pipeline With New AZD4956 Combination Trial
TIPRANKS  ·  03-28
AstraZeneca Expands DNA-Repair Oncology Pipeline With New AZD4956 Combination Trial
Shareholders Sue Inovio Pharmaceuticals Over DNA Technology Claims
TIPRANKS  ·  03-23
Shareholders Sue Inovio Pharmaceuticals Over DNA Technology Claims
Lucence, DxD Hub and NCCS launch $6 mil cancer diagnostics research collaboration
Nurdianah Md Nur  ·  03-13
Lucence, DxD Hub and NCCS launch $6 mil cancer diagnostics research collaboration
Ginkgo Bioworks Holdings Is Maintained at Sell by BTIG
Dow Jones  ·  03-12
Ginkgo Bioworks Holdings Is Maintained at Sell by BTIG
Elon Musk Endorses 'Fundable' Jurassic Park: These De-Extinction Companies Are Already Making It Happen
Benzinga_recent_news  ·  03-08
Elon Musk Endorses 'Fundable' Jurassic Park: These De-Extinction Companies Are Already Making It Happen
AKESO Shares Surge Over 6% in Morning Session on Novel Brain Cancer Treatment Collaboration
Stock News  ·  03-05
AKESO Shares Surge Over 6% in Morning Session on Novel Brain Cancer Treatment Collaboration
4basebio bolsters commercial leadership to drive synthetic DNA growth
TIPRANKS  ·  03-03
4basebio bolsters commercial leadership to drive synthetic DNA growth
Ginkgo Bioworks Launches Ginkgo Cloud Lab to Provide Remote Access for Researchers
MT Newswires Live  ·  03-02
Ginkgo Bioworks Launches Ginkgo Cloud Lab to Provide Remote Access for Researchers
A Look At Ginkgo Bioworks (DNA) Valuation As It Pivots To Robotics Labs And Biosecurity Divestiture
Simply Wall St.  ·  03-02
A Look At Ginkgo Bioworks (DNA) Valuation As It Pivots To Robotics Labs And Biosecurity Divestiture
Ginkgo Bioworks posts fall in Q4 revenue; co to divest biosecurity business
Reuters  ·  02-27
Ginkgo Bioworks posts fall in Q4 revenue; co to divest biosecurity business
Ginkgo Bioworks Holdings Q4 EPS $(1.41) Misses $(1.36) Estimate, Sales $33.318M Miss $37.617M Estimate
Benzinga  ·  02-27
Ginkgo Bioworks Holdings Q4 EPS $(1.41) Misses $(1.36) Estimate, Sales $33.318M Miss $37.617M Estimate
Ginkgo Bioworks Holdings Inc: Deal in Exchange for a Minority Equity Position in Biosecurity Business Alongside Investors
THOMSON REUTERS  ·  02-27
Ginkgo Bioworks Holdings Inc: Deal in Exchange for a Minority Equity Position in Biosecurity Business Alongside Investors
Ginkgo Bioworks Q4 Net Income USD -81 Million
THOMSON REUTERS  ·  02-27
Ginkgo Bioworks Q4 Net Income USD -81 Million
Press Release: Ginkgo Bioworks Reports Fourth Quarter and Full Year 2025 Financial Results, Announces Focus on Autonomous Labs Offerings and Divestiture of its Non-Core Biosecurity Business
Dow Jones  ·  02-27
Press Release: Ginkgo Bioworks Reports Fourth Quarter and Full Year 2025 Financial Results, Announces Focus on Autonomous Labs Offerings and Divestiture of its Non-Core Biosecurity Business

Introduction

Company Name.
Ginkgo Bioworks Holdings Inc.
Affiliated Markets:
NYSE
Listing Date:
--
Main Business:
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
Issue price:
--